Experts help bring first-of-its-kind drug for metabolic liver disease to the clinic

  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 45 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 51%

United Kingdom Headlines News

United Kingdom Latest News,United Kingdom Headlines

Liver disease specialists at the University of Chicago Medicine will soon begin prescribing a first-of-its-kind drug for treating advanced metabolic dysfunction-associated steatotic liver disease (MASLD)—formerly known as nonalcoholic fatty liver disease (NAFLD).

Experts help bring first-of-its-kind drug for metabolic liver disease to the clinic retrieved 15 March 2024 from https://medicalxpress.com/news/2024-03-experts-kind-drug-metabolic-liver.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.

Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 101. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Team performs the first gene therapy tests in a whole human liverIn a worldwide first-of-its-kind study published in the journal Nature Communications this week, a team of scientists from Children's Medical Research Institute (CMRI) have tested novel gene therapies in a whole human liver, with the goal of developing more effective treatments for life-threatening inherited diseases.
Source: medical_xpress - 🏆 101. / 51 Read more »

Rising alcohol-related liver cancer prompts new prediction toolLiver cancer is the sixth most common cancer and the third most frequent cause of cancer-related death globally. However, its distribution and causes vary greatly across different regions. While areas like Eastern Asia and sub-Saharan Africa see the most cases, the reasons behind them differ significantly.
Source: medical_xpress - 🏆 101. / 51 Read more »

Study shows how estrogen protects against fatty liverNew research from Karolinska Institutet shows how estrogen protects against MASLD, a fatty liver disease that has increased dramatically during the current obesity epidemic. The study, published in Molecular Systems Biology, shows how a new drug under development could become a future treatment for fatty liver disease and liver cancer.
Source: medical_xpress - 🏆 101. / 51 Read more »

Key protein identified in protecting women from fatty liver diseaseNew research from Karolinska Institutet in Sweden shows how oestrogen protects against MASLD, a fatty liver disease that has increased dramatically during the current obesity epidemic.
Source: NewsMedical - 🏆 19. / 71 Read more »

What's behind the surge of fatty liver disease in Latinx kids?For Latinx kids, unreliable access to food at age 4 raises the odds of having fatty liver disease later in childhood by nearly four times, a new UC San Francisco-led study found.
Source: medical_xpress - 🏆 101. / 51 Read more »

Immune cells in the liver eat up excess cholesterol, study revealsA new study from Karolinska Institutet in Sweden reveals that immune cells in the liver react to high cholesterol levels and eat up excess cholesterol that can otherwise cause damage to arteries.
Source: NewsMedical - 🏆 19. / 71 Read more »